Selected clinical research publications

  • Smyth D, D Webster, L Barrett, M MacMillan, L McKnight, and F Schweiger. Transitioning to highly effective therapies for the treatment of chronic hepatitis C virus infection: a policy statement and implementation guideline. In press at Canadian Journal of Gastroenterology and Hepatology
  • Kohli A, A Osinusi, Z Sims, A Nelson, EG Meissner, L Barrett,  D Bon, MM Marti, R Silk, C Kotb, C Gross, T Jolley, S Sidharthan, T Petersen, K Townsend, D Egerson, R Kapoor, E Spurlin, M Sneller, M Proschan, E Herrmann, R Kwan, G Teferi, R Talwani, G Diaz, D Kleiner, B Wood, J Chavez, S Abbott, WT Symonds, GM Subramanian, PS Pang, J McHutchison, MA Polis, AS Fauci, H Masur, S Kottilil. Directly acting triple drug anti-HCV therapy induces complete virologic response with a six week regimen. In press at Lancet
  • Osinusi A, EG Meissner, YJ Lee, L Heytens, A Nelson, M Sneller, A Kohli, L Barrett, M Proschan, E Herrmann, B Shivakumar, W Gu, R Kwan, G Teferi, R Talwani, R Silk, C Kotb, S Wroblewski, D Fishbein, R Dewar, H Highbarger, X Zhang, D Kleiner, BJ Wood, J Chavez, W Symonds, M Subramanian, J McHutchison, MA Polis, AS Fauci, H Masur, S Kottilil. 2013. Sofosbuvir and ribavirin for hepatitis C genotype 1 in patients with unfavorable treatment characteristics: a randomized clinical trial. JAMA 310(8): 804.

Selected scientific research publications

  • Kohli A, EG Meissner, E Funk, L Barrett, B Santich, A Shaffer, P Burbelo, J Johl, B Shivakumar, M Polis, H Masur, S Moir, S Kottilil. Persistently elevated abnormal B-cell subpopulations and anti-core antibodies in patients co-infected with HIV/HCV who relapse. In press at Journal of Medical Virology
  • Barrett L, SN Stapleton, ME Gallant, NJ Fudge and MD Grant.  2014. Immune resilence in human immunodeficiency virus-infected individuals seronegative for cytomegalovirus. AIDS 28(14): 2045.
  • Zipperlen K, M Gallant, S Stapleton, L Barrett, and M Grant. 2014. Protective genotypes in HIV infection reflect superior function of KIR3DS1+ over KIR3DL1+ CD8+ T cells. Immunology and Cell Biology doi: 10.1038/icb.2014.68
  • Barrett L, N Trehanpati, S Poonia, L Daigh, SK Sarin, H  Masur, S Kottilil. 2014. Hepatic compartmentalization of exhausted regulatory cells in HIV/HCV coinfected patients. Journal of Viral Hepatitis doi: 10.1111/jvh.12
  • Cortez KJ, MA Proschan, L Barrett, AU Neumann, DG Brust, E Formentini, MG Ghany, RT Davey, H Masur, MA Polis, S Kottilil. 2013. Baseline CD4+ T Cell counts predict HBV viral kinetics to adefovir treatment in lamivudine resistant HBV-infected patients with or without HIV infection. HIV Clinical Trials 14(4): 149.
  • Barrett L, KR Fowke and MD Grant. 2012. Cytomegalovirus, aging and human immunodeficiency virus infection: a perfect storm. AIDS Reviews 14(3): 159.
  • Barrett L, M Gallant, C Howley, MI Bowmer, G Hirsch, K Peltekian, M Grant.  2011. Stronger hepatitis C virus-specific CD8+ T cell responses in HIV coinfection.  Journal of Viral Hepatitis 18(3):170-180.
  • Barrett L, CM Dai, J Gamberg, M Gallant, M Grant.  2007.  Circulating CD14-CD36+ peripheral blood mononuclear cells constitutively produce interleukin-10.  Journal of Leukocyte Biology 82: 152.

Access all publications through PubMed